Literature DB >> 2199468

Interaction of growth factors during progression towards steroid independence in T-47-D human breast cancer cells.

R J Daly1, R J King, P D Darbre.   

Abstract

When deprived of steroid in the long term, T-47-D human breast cancer cells lose estrogen sensitivity of cell growth. This loss of response results from an increased basal growth rate in the absence of steroid, not from a loss of estrogen-stimulated growth, and it occurs without any loss of estrogen receptor number or function. Growth factor gene expression and sensitivity have been investigated in this model system in an attempt to unravel the molecular mechanisms underlying the progression to steroid autonomy. The transition was accompanied by a decreased dependence on added serum and by a loss of the stimulatory effects of insulin and basic fibroblast growth factor, but also by an acquired sensitivity to stimulation by transforming growth factor-beta (TGF-beta). An increase in TGF-beta 1 mRNA was detected following loss of steroid sensitivity. There was no increase in epidermal growth factor (EGF) receptor number. These findings are discussed in relation to current knowledge concerning the mechanisms by which estrogens stimulate breast cancer cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2199468     DOI: 10.1002/jcb.240430302

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  8 in total

1.  Overexpression of insulin-like growth factor II (IGFII) in ZR-75-1 human breast cancer cells: higher threshold levels of receptor (IGFIR) are required for a proliferative response than for effects on specific gene expression.

Authors:  K Abdul-Wahab; D Corcoran; A Perachiotti; P D Darbre
Journal:  Cell Prolif       Date:  1999-10       Impact factor: 6.831

Review 2.  Complex role of tumor cell transforming growth factor (TGF)-beta s on breast carcinoma progression.

Authors:  K M Koli; C L Arteaga
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-10       Impact factor: 2.673

Review 3.  The multifunctional role of transforming growth factor (TGF)-beta s on mammary epithelial cell biology.

Authors:  C L Arteaga; T C Dugger; S D Hurd
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

Review 4.  Mechanisms of hormone resistance in breast cancer.

Authors:  K B Horwitz
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

5.  Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.

Authors:  C L Arteaga; S D Hurd; A R Winnier; M D Johnson; B M Fendly; J T Forbes
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

Review 6.  IGF-I and IGF-II expression in human breast cancer xenografts: relationship to hormone independence.

Authors:  N Brünner; C Moser; R Clarke; K Cullen
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

7.  Loss of growth inhibitory effects of retinoic acid in human breast cancer cells following long-term exposure to retinoic acid.

Authors:  R Stephen; P D Darbre
Journal:  Br J Cancer       Date:  2000-11       Impact factor: 7.640

Review 8.  Endocrine Disruptors Leading to Obesity and Related Diseases.

Authors:  Demetrios Petrakis; Loukia Vassilopoulou; Charalampos Mamoulakis; Christos Psycharakis; Aliki Anifantaki; Stavros Sifakis; Anca Oana Docea; John Tsiaoussis; Antonios Makrigiannakis; Aristides M Tsatsakis
Journal:  Int J Environ Res Public Health       Date:  2017-10-24       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.